Abstract

We report the genetic analysis of autosomal dominant, nonsyndromic, progressive sensorineural hearing loss in a Chinese family. Using whole exome sequencing, we identified a missense variant (c.130C>T, p.R44C) in the MCM2 gene, which has a pro-apoptosis effect and is involved in the initiation of eukaryotic genome replication. This missense variant is very likely to be the disease causing variant. It segregated with hearing loss in this pedigree, and was not found in the dbSNP database or databases of genomes and SNP in the Chinese population, in 76 patients with sporadic hearing loss, or in 145 normal individuals. We performed western blot and immunofluorescence to test the MCM2 protein expression in the cochlea of rats and guinea pigs, demonstrating that MCM2 was widely expressed in the cochlea and was also surprisingly expressed in the cytoplasm of terminally differentiated hair cells. We then transiently expressed the variant MCM2 cDNA in HEK293 cells, and found that these cells displayed a slight increase in apoptosis without any changes in proliferation or cell cycle, supporting the view that this variant is pathogenic. In summary, we have identified MCM2 as a novel gene responsible for nonsyndromic hearing loss of autosomal dominant inheritance in a Chinese family.

Highlights

  • Hearing loss is the most common form of sensory impairment in humans

  • Hereditary hearing loss can be subdivided into nonsyndromic hearing loss and syndromic hearing loss according to the clinical manifestations [1,2,3]

  • We explored the expression pattern of maintenance complex component 2 gene (MCM2) in the terminally differentiated hair cells of cochlea and the results consisted with the previous conclusion that a minor level of MCM2 was expressed in hair cells by DNA microarray [24]

Read more

Summary

Introduction

Hearing loss is the most common form of sensory impairment in humans. About half of the occurrences of hearing loss are caused by genetic factors. Hereditary hearing loss can be subdivided into nonsyndromic hearing loss and syndromic hearing loss according to the clinical manifestations [1,2,3]. Syndromic deafness has abnormalities in other parts of the body, and accounts for about 30% of hereditary hearing loss. No symptoms or signs are found in other parts of the body in nonsyndromic hearing loss, which accounts for about 70% of hereditary hearing loss [2]. 75–80% of patients show an PLOS ONE | DOI:10.1371/journal.pone.0133522. 75–80% of patients show an PLOS ONE | DOI:10.1371/journal.pone.0133522 July 21, 2015

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.